PHBI — Pharmagreen Biotech Balance Sheet
0.000.00%
- $0.53m
- $0.88m
Annual balance sheet for Pharmagreen Biotech, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2018 September 30th | 2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.152 | 0.063 | 0.012 | 0.025 | 0.008 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.032 | 0.011 | 0 | 0 | 0 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.198 | 0.189 | 0.266 | 0.373 | 0.209 |
Net Property, Plant And Equipment | 0.251 | 0.441 | 0 | — | — |
Other Long Term Assets | |||||
Total Assets | 0.449 | 0.63 | 0.266 | 0.373 | 0.209 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.84 | 1.46 | 3.17 | 2.03 | 1.91 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Liabilities | 1.84 | 1.46 | 3.15 | 2.02 | 1.98 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -1.39 | -0.833 | -2.89 | -1.65 | -1.78 |
Total Liabilities & Shareholders' Equity | 0.449 | 0.63 | 0.266 | 0.373 | 0.209 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |